Foamix Pharmaceuticals Ltd.·4

May 10, 5:34 PM ET

RIGEL DARRELL S 4

4 · Foamix Pharmaceuticals Ltd. · Filed May 10, 2018

Insider Transaction Report

Form 4
Period: 2018-05-08
Transactions
  • Award

    Options

    2018-05-08+24,94724,947 total
    Exercise: $5.06Exp: 2028-05-08Ordinary Shares (24,947 underlying)
Footnotes (2)
  • [F1]Each option represents a contingent right to purchase one ordinary share of the issuer.
  • [F2]The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 8, 2019.

Documents

1 file
  • 4
    zk1821662.xmlPrimary

    OWNERSHIP DOCUMENT